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Proteinscanbeacetylatedatthealpha-aminogroupoftheN-terminalaminoacid(methionineorthepenultimateaminoacidafter
methionine removal) or at the epsilon-amino group of internal lysines. In eukaryotes the majority of proteins are N-terminally
acetylated, while this is extremely rare in bacteria. A variety of studies about N-terminal acetylation in archaea have been reported
recently, and it was revealed that a considerable fraction of proteins is N-terminally acetylated in haloarchaea and Sulfolobus, while
this does not seem to apply for methanogenic archaea. Many eukaryotic proteins are modiﬁed by diﬀerential internal acetylation,
which is important for a variety of processes. Until very recently, only two bacterial proteins were known to be acetylation targets,
but now 125 acetylation sites are known for E. coli. Knowledge about internal acetylation in archaea is extremely limited; only two
target proteins are known, only one of which—Alba—was used to study diﬀerential acetylation. However, indications accumulate
that the degree of internal acetylation of archaeal proteins might be underestimated, and diﬀerential acetylation has been shown to
be essential for the viability of haloarchaea. Focused proteomic approaches are needed to get an overview of the extent of internal
protein acetylation in archaea.
1.Introduction
Many diﬀerent forms of posttranslational modiﬁcations of
proteins have been characterized. Posttranslational modiﬁ-
cations can inﬂuence many diﬀerent features of proteins, for
example, their folding, activity, stability, antigenicity, intra-
cellular localization, and interaction with other proteins or
with nucleic acids. The fraction of posttranslationally mod-
iﬁed proteins and thus the importance of posttranslational
modiﬁcation is generally believed to be very diﬀerent for
eukaryotes—having a high fraction of modiﬁed proteins—
and prokaryotes, which are thought to harbor only very few
modiﬁed proteins.
For eukaryotes it is thought that acetylation is the most
common covalent modiﬁcation out of 200 types that have
been reported [1]. It has also been argued that acetylation
is a regulatory modiﬁcation of the same importance as
phosphorylation [2]. The arguments were that acetylation,
like phosphorylation, aﬀects many diﬀerent proteins, can
have a variety of consequences, and can regulate key
cellular processes in response to extracellular signals [2].
Nevertheless, the wealth of experimental data on protein
p h o s p h o r y l a t i o ni ne u k a r y o t e si sm u c hh i g h e rt h a no n
acetylation,andinaddition,itwastypicallygeneratedearlier.
In stark contrast to eukaryotic proteins, until very
recently only very few bacterial proteins were known to
be acetylated. It has long been thought that this would
also be true for archaeal proteins, and thus several years
ago it was summarized that the available results underscore
the conviction that N-terminal acetylation is fundamentally
diﬀerent in eukaryotes compared to archaea and bacteria
[3]. The belief that protein acetylation plays an insigniﬁcant
role in Archaea also held true in the archaeal community
for example, in a review about “posttranslation protein
modiﬁcation in Archaea” only about 1% of the text was
dedicated to protein acetylation [4].
However, results obtained during recent years have
revealed that this belief is far from being true and that—
in contrast—N-terminal protein acetylation adds to the
ever growing number of biological functions that combine
eukaryotes and archaea to the exclusion of the bacteria.
Earlier recognized examples of similarity between eukaryotic
and archaeal systems are the proteins and DNA elements of
the transcription initiation machinery [5, 6], the presence of2 Archaea
histones [7], the translation initiation factor repertoire [8],
and replication proteins [9].
However, the information about protein acetylation in
archaea is still pretty limited. Therefore, this paper plays
a dual role on the one hand it will summarize the results
about protein acetylation in archaea, and on the other hand
it has the hope to nudge further research in this fascinating
and mainly unexplored area. Two diﬀerent types of protein
acetylation are known, which will be discussed sequentially,
that is, (1) the acetylation of the alpha-amino group of the
N-terminal amino acid of proteins and (2) the acetylation
of the epsilon-amino group of internal lysine residues. The
former reaction is irreversible, and acetylated proteins stay
modiﬁed until their degradation, in contrast to the latter,
which is reversible and its biological role is thought to be
the diﬀerential regulation of proteins, for example, the DNA-
binding aﬃnity of histones, the most extensively studied
example of internally acetylated eukaryotic proteins.
2. N-Terminal ProteinAcetylationin
EukaryotesandinBacteria
The occurrence of N-terminal acetylation of proteins in
eukaryotes was discovered very early; the ﬁrst example was
described in 1958. In the next decades many examples
were found, typically when protein sequencing via the
standard method of that time, Edman degradation, was
unsuccessful because the N-terminus was “blocked” and
alternative methods were developed to unravel the nature
of the chemical modiﬁcation of the alpha amino group. In
a review in 1985, already more than 300 examples were
listed, which represented more than 100 diﬀerent proteins,
many of which had been analyzed from several species
[10].Recently,techniqueshavebeendevelopedtospeciﬁcally
enrich N-terminal peptides and use mass spectrometric
techniques for large-scale analyses of the correct start codon,
methionine removal, and covalent modiﬁcation of the
alpha amino group [11, 12]. Examples for their application
are the determination of more than 900 N-termini from
human HELA cells and of more than 1200 N-termini from
Drosophila melanogaster proteins [13, 14]. The new large-
scale studies underscore that knowledge about N-terminal
protein acetylation in eukaryotes reviewed earlier [1, 3]s t i l l
holds true and give it a higher statistical validation. The
identity of the N-terminal amino acid is determined by the
activity of the methionine aminopeptidase (MAP). In fact
the methionine is removed by MAP from the vast majority
of eukaryotic proteins, and thus most proteins start with
the second (penultimate) amino acid of the genomically
encoded open reading frame. Eukaryotes contain three
diﬀerent N-terminal acetyltransferases (Nat) termed NatA,
NatB, and NatC, which have diﬀerent substrate speciﬁcities.
They acetylate a high fraction of proteins, for example,
around 60% in yeast, 30% in D. melanogaster, and more
than 80% in humans [14, 15]. NatA acetylates proteins
beginning with the N-terminal amino acids Ser, Ala, Gly, or
Thr. Therefore NatA depends on the prior action of MAP.
As the N-terminal methionine is removed from the majority
of proteins, NatA is the major player responsible for N-
terminal acetylation. It could be shown that NatA is highly
conserved and a yeast NatA mutant could be rescued by
human NatA, which acetylated in yeast nearly the same set of
proteins as the endogenous NatA, albeit only partially [15].
NatB is speciﬁc for proteins starting with methionine and a
bulky hydrophobic amino acid in the second (penultimate)
position, while NatC is speciﬁc for the N-termini Met-Glu
and Met-Asp. NatB and NatC are therefore independent
of methionine removal by MAP. N-terminal acetylation
in eukaryotes occurs cotranslationally, when the amino
terminus leaves the ribosome and is complete when the ﬁrst
40–50 amino acids have been synthesized [3, 16]. In spite
of the fact that N-terminal protein acetylation in eukaryotes
is known for more than 50 years, the biological function
of acetylation of a major fraction of proteins is still not
really known. For several proteins, diﬀerences between the
acetylated and nonacetylated form have been described,
including diﬀerential activity, biological half life, or thermal
stability [3, 17] ,b u tag e n e r a lr o l eo fa c e t y l a t i o nh a sn o t
yet been found. An obvious function that has repeatedly
been discussed is stabilization of proteins from proteolytic
degradation, and the ﬁnding that acetylated proteins are
strongly overrepresented among the most abundant proteins
[18] is in line with this view. However, recently also the
opposite has been proposed, namely, that N-terminal acety-
lation creates speciﬁc degradation signals [19]. Irrespective
of the clariﬁcation of these opposing views, it is clear that N-
terminal acetylation is of great signiﬁcance in vivo,b e c a u s e
single deletion mutants of all three genes encoding the
three Nats in yeast are highly impaired. Characterization of
the human homologs has revealed that depletion of hNatB
results in a disruption of normal cell cycle progression, while
depletion of hNatC induces apoptosis and cell death[20, 21].
In stark contrast to the high fraction of N-terminally
acetylatedproteinsineukaryotes,onlyveryfewproteinswere
found to be N-terminally acetylated in bacteria. Only ﬁve
E. coli proteins are known to be N-terminally acetylated,
three of them being the ribosomal proteins S5, S12, and
S18. In contrast to eukaryotes, acetylation in E. coli occurs
posttranslationally.AcetylationofS12hasbeenshowntosta-
blize the ribosomal stalk complex [22]. Three proteins with
Nat activity are known, RimI, RimJ, and RimL. However,
at least RimJ has a dual function; a native RimJ as well as
an acetylation-deﬁcient variant could suppress the diﬀerent
phenotypes of a ribosomal protein S5 (G28D) mutation,
that is, cold-sensitivity, anomalous ribosomal proﬁles and
mRNA misreading. RimJ was found to be associated with the
pre-30S subunit, and it was proposed that it is a ribosome
assembly factor in addition to being an N-terminal acetyl
transferase [23].
3. N-Terminal ProteinAcetylationin
the Archaea
Already 20 years ago it was reported that a few ribosomal
proteins of haloarchaea are acetylated at their N-terminus
[24–26]. However, this did not increase the interest inArchaea 3
protein acetylation in archaea because on the one hand it
perfectly ﬁtted to the bacterial paradigm and thus seemed
to underscore that protein acetylation is a rare event also
in archaea, and on the other hand only extremely few
reports about the acetylation of archaeal proteins appeared.
The reason why the degree of N-terminal acetylation was
overlooked for so long is probably that the acetylation
typically is only partial (see below) and that therefore
the un-acetylated fraction allowed successful N-terminal
sequencing, and therefore ample “proof” was generated
that archaeal proteins are blocked in only extreme rare
cases.
One large-scale proteomics study with Halobacterium
salinarum and Natronomonas pharaonis completely changed
the picture and currently dominates the view about the
degree of N-terminal acetylation in “the archaea.” It should
be noted that this is no exception but that the current
view about protein acetylation in “the eukaryotes” and “the
bacteria” is also based on studies with only one or very few
species. The above-mentioned large-scale proteomic study
let to the identiﬁcation of 606 N-terminal peptides from H.
salinarum a n d3 2 8N - t e r m i n a lp e p t i d e sf r o mN. pharaonis,
adding up to a sum of 934 N-termini. On the one hand,
the results were used to enhance the reliability of start
codon assignments, which is not trivial in high G+C-rich
genomes,andtorevealtheextentandtherulesofN-terminal
methionine cleavage in haloarchaea [27].
On the other hand, the results were used to speciﬁcally
address the question of the degree of N-terminal protein
acetylation in haloarchaea [28]. It turned out that the N-
terminal methionine was cleaved from about two-thirds of
all haloarchaeal proteins. Cleavage occurred when the penul-
timateaminoacidwassmall(glycine,alanine,proline,valine,
serine, threonine). The substrate speciﬁcity for haloarchaeal
methionine aminopeptidases (MAPs) matches the speciﬁcity
of bacterial and eukaryotic MAPs, and thus the biochemistry
of methionine removal appears to be universally conserved.
Surprisingly, it was found that N-terminal acetylation is not
uncommon in haloarchaea, but that 14% to 19% of the
proteins are N-terminally acetylated.
This is in stark contrast to E. coli and reminds more of
the situation in eukaryotes; albeit the fraction of acetylated
proteins is somewhat smaller. Acetylation occurred nearly
exclusively after methionine removal, and only serine and
alanine as penultimate amino acids were acetylated [28]. It
was found that also the antepenultimate position (position
three of the open reading frame and position two in the
protein after methionine removal) has a strong inﬂuence
on protein acetylation. Acetylation is favoured when serine,
alanine, and glycine are in the antepenultimate position,
while, in contrast, aspartic acid and glutamic acid in this
position strongly interfere with acetylation. Therefore, while
thedegreeofacetylationsomewhatresemblesthatofeukary-
oticproteins,thesubstratespeciﬁcitiesoftherespectiveNATs
are diﬀerent as eukaryotic proteins are regularly acetylated
when acidic amino acids are in the antepenultimate position
[3]. The acetylation pattern is most similar to the substrate
speciﬁcity of the yeast NatA enzyme, while NatB- and NatC-
like activities are missing in haloarchaea.
Very few exceptions from the “haloarchaeal acetylation
rules” were observed, most of which were conserved between
both species. Examples are the alpha subunit of the pro-
teasome (see below), the beta subunit of prefoldin and a
hypothetical protein. This indicates that in addition to one
or more general Nats, also one or very few additional acetyl
transferases with a very high substrate speciﬁcity exist in
haloarchaea.
It was also shown that the acetylation eﬃciency for
the majority of acetylated proteins is not 100%, but that
it diﬀered protein speciﬁcally from 13% to 100%. This
could be an indication that N-terminal protein acetylation in
archaea does not occur cotranslationally, like in eukaryotes,
but posttranslatinally. While the genes for putative Nats
have been detected in haloarchaeal genomes, as yet no
experimental data about the molecular mechanism of N-
terminal acetylation are available.
A few additional proteomic studies enable ﬁrst esti-
mations about how general these results are true for “the
archaea.” A proteomic study with a third haloarchaeon,
Haloferax volcanii, representing a third genus, mostly under-
scored the results of the study discussed above [29]. N-
terminal peptides of 236 proteins were identiﬁed, and the
initial methionine was removed in 70% of all cases. 29% of
all proteins were N-terminally acetylated, a fraction that is
somewhathigherthanfortheothertwohaloarchaealspecies.
One explanation could be that the degree of acetylation is
higherinHaloferax thaninHalobacteriumandNitrosomonas;
an alternative explanation could be that the fraction of
identiﬁed proteins was lower for H. volcanii and that the
degree of acetylation is higher for abundant proteins (like in
eukaryotes). Nevertheless, the study showed that signiﬁcant
N-terminal acetylation occurs in at least three diﬀerent
haloarchaeal genera and thus can probably be generalized to
all haloarchaea.
T h es i t u a t i o ns e e m st ob ed i ﬀerent for another group
of the Euryarchaeota, the methanogenic archaea. Two pro-
teomic studies are available for Methanococcus jannaschii,
which identiﬁed 72 proteins and 963 proteins, respectively
[30, 31]. Only a single acetylation site at an internal lysine
was reported [30], while N-terminal acetylation is not
mentioned at all. Of course one explanation could be that
it was overlooked based on the—at that time—general belief
that it does not occur in archaea anyhow. However, I ﬁnd it
more probable to assume that it would have been detected,
like in haloarchaea, if it would also occur in methanogenic
archaea. Therefore, the two proteomics studies as well as
many studies about individual proteins can be taken as
an indication that N-terminal acetylation in methanogenic
archaea is very rare or does not occur.
A very limited proteomic survey of N-terminal acety-
lation was performed with Sulfolobus solfataricus, a species
belonging to the kingdom of Crenarchaeota [32]. Of the 26
N-terminal peptides identiﬁed, 17 were acetylated. Although
no“percent”valuescanbecalculatedduetothelowabsolute
numbers of proteins, the fraction of N-terminally acetylated
proteins appears to be much higher than for haloarchaea.
Clearly a more general study is needed to clarify if these
values are of statistical signiﬁcance. If this would turn out4 Archaea
to be true, Sulfolobales and maybe Crenarchaeota as a whole
would be more alike eukaryotes than all hitherto tested
species of Euryarchaeota. For both Cren- and Euryarchaeota
it was found that acetylation occurred at penultimate serine
and alanine residues, and for both groups partial acetylation
was observed.
TheS.solfataricusgenomewasfoundtocontainonegene
encoding a putative Nat (sso0209), which was named ssArd1
based on a sequence identity of 37% with the human Ard1,
a homologue of yeast NatA. The protein was heterologously
produced, and it was conﬁrmed that it can acetylate the N-
terminus of Alba, a DNA-binding protein of Sulfolobus [32].
A variety of Alba mutants as well as additional Sulfolobus
proteins were used to characterize the substrate speciﬁcity
of ssArd1. Surprisingly it was found that in addition to
N-terminal Ser and Ala (a NatA-like activity) also the N-
termini Met-Glu and Met-Leu were acetylated (NatC- and
NatB-like activity). Therefore, it was concluded that the
situation in Sulfolobus represents an ancestral state with a
single Nat, which is not part of a protein complex and
which has a broader substrate speciﬁcity compared to the
eukaryotic Nats. Eukaryotic Nats have later experienced
gene duplications and have evolved further into specialized
proteins[32].ThefactthatsomeproteinswithanN-terminal
Ala are not acetylated in vitro and in vivo was taken as a ﬁrst
indication that N-terminal acetylation in Sulfolobus might
occur posttranslationally and the degree of folding of the
N-terminus determines whether a protein is a substrate for
ssArd1.
The exceptional acetylation of the N-terminus Met-Gln
was not only found for the alpha subunit of the proteasome
in H. salinarum and N. pharaonis (see above), but also in
Haloferax volcanii [33]. In the latter species the penultimate,
Gln was mutated to several other amino acids, and the
consequences for methionine removal and acetylation in
vivo were characterized [34]. As expected, the introduction
of an Ala at the penultimate position resulted in total
methionine removal and Ala acetylation, indicating that
the protein had been switched from a speciﬁc into the
default haloarchaeal acetylation pathway. Unexpectedly the
N-terminal methionine was not removed in the two mutants
Q2S and Q2V, in contrast to the usual substrate speciﬁcity of
the haloarchaeal MAP.
Both mutants (Q2S, Q2V) were acetylated at the methio-
nine, indicating that the presumed speciﬁc acetylase can
tolerate Ser and Val at the penultimate position. Three other
mutations (Q2D, Q2P, Q2T) resulted in protein mixtures
comprised of methionine cleaved and uncleaved, acetylated
and unacetylated forms, indicating that these variants are
partial substrates for MAP and speciﬁc/default Nat [34].
Clearly, further research is needed to identify the presumed
speciﬁc Nat and unravel its molecular mechanism. While it
does not belong to the topic of this paper, it is interesting
to note that the diﬀerent single amino acid mutants aﬀected
the phenotype of the cells, for example, osmotolerance, ther-
motolerance,orgrowthrate,underscoringtheimportanceof
the proteasome for the physiology of haloarchaea [34].
Also the yeast proteasome, which consists of seven
diﬀerent alpha and seven diﬀerent beta subunits, is target
for N-terminal acetylation. In contrast to haloarchaea, no
speciﬁc Nat is required, but acetylation is performed by
the defaults Nats. However, the situation is rather complex:
NatA,NatB,andNatCareallrequiredandresponsibleforthe
N-terminal acetylation of a speciﬁc subset of subunits [35].
4. InternalProteinAcetylation in
EukaryotesandBacteria
In eukaryotes many proteins are diﬀerentially acetylated at
the epsilon-amino group of internal lysines. Only very little
is known about internal protein acetylation in archaea (see
below), therefore the overview about internal acetylation
in eukaryotes will be kept rather short. By far the most
studied eukaryotic target proteins for internal acetylation
are the histones, which in addition to acetylation can be
posttranslationally modiﬁed by phosphorylation, methyla-
tion, ubiquitination, and ADP ribosylation [36]. Acetylation
shields the charge of the lysine amino group and therefore
decreases the binding aﬃnity to DNA; therefore diﬀerential
acetylation is a means for the regulation of gene expression
via diﬀerential DNA compaction. Several families of histone
acetyltransferases(HATs)andhistonedeacetylases(HDACs)
e x i s ti ne u k a r y o t e s( e . g . ,[ 37, 38]). The names HAT and
HDAC are used even when the enzymes have also or even
only other targets than histones. Special interest has been
given to the Sir2 subfamily of protein deacetylases (also
called Sirtuins), which are highly conserved and occur not
only in eukaryotes, but also in bacteria and archaea. They
are NAD-dependent deacetylases and have been shown
to be involved not only in a variety of gene regulatory
pathways, but also metabolism, cell motility, multicellular
development in social amoeba, longevity in response to
caloric restriction, and diﬀerent kinds of cancers [39–42].
Therefore especially HDACs have been tested as possible
targets for anticancer treatments, and HDAC inhibitors have
in fact entered Phase I clinical trials [43]. Today many
diﬀerent proteins in addition to histones are known to
be regulated by diﬀerential acetylation [17, 44] including
the cytoskeleton protein tubulin [45, 46]. Acetylation can
have an inﬂuence on transcriptional regulation, pre-mRNA
splicing, protein stability, protein interactions, cell cycle,
circadian rhythm, and others [17].
Untilveryrecentlyitwasbelievedthatinbacteriainternal
acetylation hardly occurs at all. Only two proteins were
known to be acetylated at an internal lysine, that is, the
chemotaxis protein CheY and the acetyl-CoA synthase. A
protein acetyl transferase (PAT) and the deacetylase CobB
(belonging to the Sir2 family) have been identiﬁed, which
regulate the acetylation level of both proteins [47–51].
However, an aﬃnity enrichment of acetylated peptides from
E. coli led to the identiﬁcation of 125 acetylation sites in
85 proteins, indicating that internal acetylation is much
more common in bacteria than previously thought [52].
The proteins belong to a variety of functional classes,
for example, protein synthesis, carbohydrate metabolism,
nucleotide metabolism, and TCA cycle. 83 of the 125 acetyla-
tion sites were exclusively modiﬁed during stationary phaseArchaea 5
and deacetylated when stationary phase E. coli cells were
inoculated into fresh medium. Therefore, it has been argued
that the main biological function of internal acetylation in E.
coli might be the downregulation of protein activities during
phases of starvation [52]
5. Differential Internal ProteinAcetylation
IsEssentialatLeast for Haloarchaea
One genetic approach has been performed to elucidate the
importance of internal protein acetylation for the haloar-
chaeal species H. volcanii [53] .T h eg e n o m eo fH. volcanii
was found to contain three genes for protein acetylases
and two genes for protein deacetylases. All three acetylases
belong to the Gcn5 family of acetylases and have been
named Pat1, Pat2 (Hvo 1756 and Hvo 1821), and Elp3
(Hvo 2888). One of the deacetylases (Hvo 2194) belongs to
the Sir2 subfamily, while the second (Hvo 0522) belongs
to the HdaI family. It was attempted to construct single
deletion mutants of all ﬁve genes. Four of the ﬁve mutants
could be generated and grew indistinguishably from the wild
type. However it turned out to be impossible to generate
the hdaI deletion mutant, indicating that the deacetylase
HdaI is essential for H. volcanii. This was experimentally
proven by the ability to delete the chromosomal hdaI gene
in a strain that carried a copy of the gene on a plasmid. As
the hdaI gene overlaps and is cotranscribed with the gene
encoding the histone, it is reasonable to assume that the
histone is one substrate for HdaI. It remains to be clariﬁed
whether diﬀerential histone acetylation is essential for H.
volcanii or whether the acetylation of other target proteins of
HdaI is responsible for the phenotype. While single mutants
of all three acetylase genes could be obtained, the pat2
elp3 double mutant could not be generated. Therefore, the
two genes are synthetically lethal indicating that they have
overlapping substrate speciﬁcities and that the acetylation
of at least one protein is essential for H. volcanii.T h ef a c t
that the ability for reversible internal protein acetylation
is essential for H. volcanii underscores the importance for
this posttranslational modiﬁcation at least for this archaeal
species. As genetic techniques for other archaeal species have
been developed [54, 55], it will be interesting to clarify
whether this is also true for additional species and can be
g e n e r a l i z e dt om a n yo ra l lA r c h a e a .
6. InternalProteinAcetylation in
the Archaea:ALBA andaLittleBit More
The ﬁrst archaeal protein with an internally acetylated lysine
was reported as early as 1978; it was a 2Fe-2S ferredoxin
from H. salinarum (at that time named H. halobium), which
was monoacetylated on lysine 118 near the C-terminus [56].
Shortly thereafter it was reported that the homologous 2Fe-
2S ferredoxin from H. marismortui (at that time named
“Halobacterium from the Dead Sea”) was acetylated at
the equivalent position [57]. However, these observations
did not trigger subsequent interest in diﬀerential protein
acetylation in archaea and are today known by only few
researchers.
Obvious candidates as targets for internal acetylation
are the archaeal histones. It has long been argued that
archaeal histones lack the N-terminal domain of eukaryotic
histones, which are heavily posttranslationally modiﬁed and
can therefore not be acetylated. However, meanwhile it has
been found that also positions in the conserved histone core
domain of eukaryotic histones are acetylated [58]. How-
ever, a proteomic approach that speciﬁcally addressed the
question of histone acetylation in Methanococcus jannaschii
and Methanosarcina acetivorans came to the conclusion that
histoneacetylationdoesnotoccurineitherofthetwospecies
[59]. Cotranscription of the histone gene with the gene
of a deacetylase in H. volanii indicates that this might be
diﬀerent in haloarchaea and candidate lysines, which are
acetylated in eukaryotes, are conserved in haloarchaea [53],
but experimental proof is still missing.
In the meantime another chromatin protein became
the second known target for internal protein acetylation in
archaea.ItisanS.solfataricusproteinthathadoriginallybeen
named Sso10b and was renamed “Alba” (acetylation lowers
binding aﬃnity) [60]. In this case the observation triggered
an intensive characterization of diﬀerential acetylation and
the responsible enzymes. It was shown that Alba carries two
acetyl groups; on the one hand it is N-terminally acetylated,
and on the other hand the epsilon-amino group of lysine
16 is acetylated [60]. The Sulfolobus member of the Sir2
(Sirtuin) protein family can deacetylate Alba in a NAD-
dependent manner. The nonacetylated Alba could repress
transcription in an in vitro transcription assay, in contrast to
the acetylated protein, and the diﬀerent activities of the two
forms were veriﬁed after deacetylation of the native protein
in vitro with Sir2 [60]. The sequence of the Salmonella
protein acetyl transferase (PAT) was used to identify the
Sulfolobus homologue, and it was shown that Sulfolobus PAT
can acetylate Alba in vitro with a very high eﬃciency at the
native target amino acid, lysine 16 [61]. The acetylation was
shown to reduce the aﬃnity of Alba for double-stranded
D N Aa sw e l la sR N Ab yaf a c t o ro ft w o[ 61]. The rather
moderate inﬂuence of the acetylation state of Alba on DNA
binding has led to the proposal that it therefore seems
probable that the speciﬁc acetylation of lysine 16 functions
as a modular signal to other proteins rather than as a direct
modulation of DNA binding aﬃnity [62]. One interaction
partner of Alba is the DNA helicase MCM. It has been shown
that Alba strongly inhibits the activity of MCM in an in vitro
helicase assay. Acetylation of Alba reduced this antagonistic
activityofAlba,notablyatconcentrationsatwhichacetylated
Alba bound DNA, excluding an indirect eﬀect [63].
While the molecular details of the biological conse-
quences of the diﬀerent activities of Alba remain to be
clariﬁed, it seems to be clear that the acetylation state
of Alba inﬂuences the degree of “chromatin packaging”
in Sulfolobus, analogous to the diﬀerential acetylation of
eukaryotic histones. Structures of Alba from several species
are available, and its binding to DNA has been modeled
[64–66]. The structure of the Alba acetylase PAT has also
been reported [67], and further structures are on their6 Archaea
way [68, 69]. In addition, the structure of the deacetylase
Sir2 has been determined both in complex with NAD and
with an artiﬁcial substrate, an acetylated peptide derived
fromthehumanproteinp53[70,71].Therefore,thearchaeal
chromatin protein Alba together with its cognate acetylase
and deacetylase is by far the best characterized example
for the relevance and mechanism of internal acetylation in
archaea, and it has the potential to enable the understanding
of the molecular mechanism in the near future.
However, it has been proposed that Alba is not the only
acetylated protein in Sulfolobus and might not even be the
majorsubstrateforPATandSir2,becausethebindingaﬃnity
between PAT and Alba is quite low compared to cognate
acetylase/protein target pairs in eukaryotes and because PAT
is encoded in the genome of species that do not contain
Alba [61]. Another argument for the presence of more
internally acetylated proteins than currently known is that
many archaea encode not only a single but several diﬀerent
proteinacetylasesanddeacetylases.InH.volcanii,theprotein
levels of the protein acetylase Pat1 and the deacetylase
Sir2 (both nonessential) have been quantiﬁed using speciﬁc
antisera. It was revealed that Pat1 is constitutively present
in the cells while Sir2 is downregulated in stationary phase
(Hering and Soppa, unpublished results). This indicates that
the acetylation level of proteins increases in stationary phase,
reminiscentofthesituationthathasbeendescribedforE.coli
(see above).
The current situation concerning internal protein acety-
lation in archaea resembles the situation in bacteria before
the ﬁrst focused large scale study aiming at the identiﬁcation
of acetylated peptides was reported, which increased the
number of proven internally acetylated bacterial proteins
from two to about ninety. It seems safe to predict that also in
archaea many diﬀerent proteins are diﬀerentially acetylated
at the epsilon amino groups of internal lysines. Therefore,
focused large scale approaches to identify diﬀerentially
acetylated archaeal proteins are badly needed.
7.Novel Approachesto Investigate
Protein Acetylation
During recent years several bioinformatic approaches have
been developed for a genome-wide prediction of N-terminal
acetylationorinternalproteinacetylation[72–75].Currently
it is unclear whether the rules obtained from eukaryotic
proteins can also be used to predict acetylation in archaeal
proteomes. For N-terminal acetylation one approach has
already been modiﬁed using the H. salinarum and N.
pharaonis dataset described above [18]. For internal protein
acetylation, benchmarking of bioinformatic programs is
another reason why large-scale studies of acetylated lysines
are needed. The approach of aﬃnity isolation of peptides
with acetylated lysines and their identiﬁcation by mass
spectrometry [52] can and should also be established with
a few archaeal species. For the experimental characterization
oftheinﬂuenceofacetylation,itwouldbedesirabletobeable
to compare acetylated and nonacetylated protein variants in
vivo and in vitro. For N-terminal acetylation in Drosophila,
the (X)PX-rule (proline at ﬁrst or second position inhibits
acetylation) was used to express mutated genes in cells
and ﬂies and study the functional relevance of N-terminal
acetylation [14]. The authors propose that the (X)PX rule
could be applied universally and could be used for equivalent
approacheswithmanyotherspecies.Forinternalacetylation,
lysines have often been replaced by other amino acids, but
of course in this way not only the acetylation but also the
functionalityofthelysineislost.Tocircumventthisproblem,
a system has been established for E. coli that enables the
acetylation of internal lysines in recombinant proteins at any
desired position [76].
8. Conclusion and Outlook
Knowledge about N-terminal protein acetylation in archaea
has increased tremendously in recent years. Several large
scale studies are available, and it became obvious that a
considerable fraction of proteins is N-terminally acetylated
in haloarchaea and in Sulfolobus. The situation seems to
be diﬀerent in methanogenic archaea for which N-terminal
acetylation has not been mentioned despite the availability
of proteomic studies.
Knowledge about internal acetylation in archaea is still
very limited. Only two targets are known, and only one of
which has been experimentally characterized (cognate HAT
and HDAC, functional consequences). However, there are
ample indications that the number of internally acetylated
proteins is highly underestimated, including the presence
of Pat and Sir2 in species devoid of Alba, the presence of
several genes for HATs and HDACs in archaeal genomes,
essentiality of HdaI and Pat2/Elp3 in H. volcanii, and
diﬀerentialregulationofSir2inthesamespecies.Thecurrent
situation concerning internal acetylation of archaeal proteins
resembles the situation concerning E. coli proteins before
2008, when the number of known internal acetylation sites
was raised from two to 125 due to one proteomic study.
Similarly, the role of small noncoding RNAs (sRNAs) for
archaeal physiology was unknown a few years ago and today
their presence has been proven for any species that was
lookedat.Itcanbepredictedthatdiﬀerentialinternalprotein
acetylation in archaea is another treasure that is waiting to
be lifted. It will add an additional layer of complexity to the
increasing regulatory network in archaea.
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